Axogen Inc logo

Axogen Inc

$ 11.94 -0.31 (-2.53%) 08:08 PM EST
P/E:
At Loss
P/B:
4.86
Market Cap:
$ 504.87M
Enterprise V:
$ 527.62M
Volume:
262.35K
Avg Vol (2M):
220.54K
Also Trade In:
Volume:
262.35K
Market Cap $:
504.87M
PE Ratio:
At Loss
Avg Vol (2-Month):
220.54K
Enterprise Value $:
527.62M
PB Ratio:
4.86
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically proven and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, United Kingdom, Spain, South Korea, and several other countries.
Name Current Vs Industry Vs History
Cash-To-Debt 0.86
Equity-to-Asset 0.52
Debt-to-Equity 0.67
Debt-to-EBITDA -2.6
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 2.15
Distress
Grey
Safe
Beneish M-Score -2.55
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 66.5
9-Day RSI 64.42
14-Day RSI 62.5
6-1 Month Momentum % 8.57
12-1 Month Momentum % -45.68

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 4.52
Quick Ratio 3.71
Cash Ratio 2.46
Days Inventory 266.67
Days Sales Outstanding 53.45
Days Payable 114.5

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -2.4

Financials (Next Earnings Date:2022-11-03 Est.)

AXGN's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:AXGN

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 128.202
EPS (TTM) ($) -0.74
Beta 0.81
Volatility % 59.6
14-Day RSI 62.5
14-Day ATR ($) 0.706167
20-Day SMA ($) 10.91575
12-1 Month Momentum % -45.68
52-Week Range ($) 6.87 - 16.75
Shares Outstanding (Mil) 42.28

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Axogen Inc Filings

Document Form Filing Date
No Filing Data

Axogen Inc Analysis

Share your research

Headlines

See More
No news.